Table 3 Absolute benefit at 5 years of the most important adjuvant treatments for cancer
From: Adjuvant therapy of melanoma with interferon: lessons of the past decade
Adjuvant Regimen | Type of Cancer | % Absolute Benefit at 5-years |
|---|---|---|
IFN vs none28 | Melanoma | > 3.0 |
CMF like CT vs none63 | Breast | 4.7 |
Anthracycline based CT vs CMF like CT63 | Breast | 3.3 |
FolFox vs none64 | Colo-rectal | 5.9 |
Platinum-based CT vs none65 | Lung | 4.1 |
Platinum-based CT vs none66,67 | Ovarian | 7–9 |